← The Wire
RLAYNasdaq
Relay Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1812364
Relay Therapeutics transforms drug discovery with its Dynamo platform to create life-changing therapies for patients
$3.23B
Market cap
$19.74
Last close
+6.4%
1D
+14.2%
5D
4.2M
Volume
Price · last 39 sessions+50.8%
May 4L $12.07 · H $19.74Jun 29
122
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KBylaw Amendment · Shareholder VoteJun 9, 20268-KMaterial AgreementMay 21, 2026424B5424B5May 21, 2026424B5424B5May 19, 20268-KReg FD Disclosure · Company UpdateMay 19, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KReg FD Disclosure · Company UpdateApr 27, 20268-KReg FD Disclosure · Company UpdateMar 16, 20268-KBylaw AmendmentMar 11, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KReg FD Disclosure · Company UpdateFeb 3, 202610-Q10-QNov 6, 20258-KExecutive Change · Results of OperationsNov 6, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KExecutive ChangeJun 11, 20258-KShareholder VoteJun 6, 20258-KMaterial Agreement · Agreement TerminatedJun 4, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 26, 20258-KReg FD DisclosureJan 13, 20258-KReg FD Disclosure · Company UpdateDec 11, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KMaterial Agreement · Company UpdateSep 11, 2024424B5424B5Sep 11, 2024424B5424B5Sep 9, 20248-KReg FD Disclosure · Company UpdateSep 9, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KAgreement TerminatedJul 16, 20248-KReg FD Disclosure · Company UpdateJun 6, 20248-KShareholder VoteJun 3, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KFeb 22, 20248-KResults of OperationsFeb 22, 2024SC 13GSC 13GFeb 14, 20248-KMaterial Agreement · Equity IssuanceJan 8, 202410-Q10-QNov 2, 20238-KResults of OperationsNov 2, 20238-KReg FD Disclosure · Company UpdateOct 12, 2023SC 13GSC 13GOct 2, 202310-Q10-QAug 8, 20238-KResults of Operations · Reg FD DisclosureAug 8, 20238-KShareholder VoteMay 31, 20238-KReg FD DisclosureMay 25, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 21, 2023DEF 14ADEF 14AApr 21, 20238-KReg FD Disclosure · Company UpdateApr 18, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 2023SC 13GSC 13GFeb 3, 20238-KReg FD DisclosureJan 9, 202310-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KMaterial Agreement · Company UpdateSep 15, 2022424B5424B5Sep 13, 2022424B5424B5Sep 12, 20228-KReg FD Disclosure · Company UpdateSep 12, 20228-KReg FD DisclosureSep 8, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KExecutive ChangeJul 27, 20228-KReg FD Disclosure · Company UpdateJun 27, 20228-KBylaw Amendment · Shareholder VoteMay 27, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 5, 2022
Insider Activity
In the 90 days to Mar 9, 2026: 4 sold $903K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Catinazzo ThomasChief Financial Officer | Sell | 17,717 | $10.06 | $178K |
| Jan 28, 2026 | Bergstrom Donald APresident, R&D | Sell | 2,686 | $8.45 | $23K |
| Jan 28, 2026 | Catinazzo ThomasChief Financial Officer | Sell | 1,695 | $8.45 | $14K |
| Jan 28, 2026 | Rahmer PeterSee remarks | Sell | 1,354 | $8.45 | $11K |
| Jan 27, 2026 | Bergstrom Donald APresident, R&D | Sell | 18,895 | $7.62 | $144K |
| Jan 27, 2026 | Catinazzo ThomasChief Financial Officer | Sell | 13,820 | $7.62 | $105K |
| Jan 27, 2026 | Rahmer PeterSee remarks | Sell | 11,684 | $7.62 | $89K |
| Jan 6, 2026 | Patel SanjivPresident and CEO | Sell | 43,168 | $7.82 | $338K |
| Nov 3, 2025 | Patel SanjivPresident and CEO | Sell | 62,073 | $7.00 | $435K |
| Oct 29, 2025 | Rahmer PeterSee remarks | Sell | 21,394 | $7.50 | $160K |
| Oct 28, 2025 | Bergstrom Donald APresident, R&D | Sell | 30,897 | $7.29 | $225K |
| Oct 28, 2025 | Catinazzo ThomasChief Financial Officer | Sell | 21,664 | $7.29 | $158K |
| Oct 28, 2025 | Rahmer PeterSee remarks | Sell | 19,135 | $7.29 | $139K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance